NCT05179616 Pforzheim Tricuspid Valve Registry - Outcomes of Percutaneous Tricuspid Valve Repair
| NCT ID | NCT05179616 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Helios Klinikum Pforzheim |
| Condition | Tricuspid Regurgitation |
| Study Type | OBSERVATIONAL |
| Enrollment | 200 participants |
| Start Date | 2020-11-30 |
| Primary Completion | 2025-11-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 200 participants in total. It began in 2020-11-30 with a primary completion date of 2025-11-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The Pforzheim Tricuspid Valve Registry study is designed to confirm the safety and performance of the TriClip™ device in a contemporary real-world setting in critically ill patients. The observational trial is a prospective, single arm, open-label, single-center, post market registry.
Eligibility Criteria
Inclusion Criteria: * Subjects (\>=18 years age) have severe tricuspid regurgitation and are symptomatic despite medical therapy. * Subjects eligible to receive the TriClip™ * Subjects must provide written informed consent prior to study procedure. Exclusion Criteria: * Subjects participating in another clinical study that may impact the follow-up or results of this study.
Contact & Investigator
Ilka Ott, MD, PhD
PRINCIPAL INVESTIGATOR
Helios Klinikum Pforzheim
Frequently Asked Questions
Who can join the NCT05179616 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Tricuspid Regurgitation. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05179616 currently recruiting?
Yes, NCT05179616 is actively recruiting participants. Contact the research team at Ilka.Ott@helios-pforzheim.de for enrollment information.
Where is the NCT05179616 trial being conducted?
This trial is being conducted at Pforzheim, Germany.
Who is sponsoring the NCT05179616 clinical trial?
NCT05179616 is sponsored by Helios Klinikum Pforzheim. The principal investigator is Ilka Ott, MD, PhD at Helios Klinikum Pforzheim. The trial plans to enroll 200 participants.